Topics
- Companion Diagnostics and Personalized Medicine
- Biomarker Discovery & Validation Strategies and Regulation
- Enabling Technologies to Maximise Biomarker Identification
- Safety and Biomarkers In Clinical Development
Who should Attend
Senior level attendees from biopharmaceutical, pharmaceutical, diagnostics, biotechnology, government, academics, solution provider companies and CRO.